Bio/Pharma Business

Caribou Biosciences Gets FDA Granted Fast Track Designation for Allogeneic CAR-T Cell Therapy

April 14, 2023

FDA has granted fast track designation to Caribou Biosciences for its allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma.

Novo Nordisk and Aspect Biosystems Enter Strategic Partnership

April 14, 2023

Under this partnership, the two companies will develop bioprinted tissue therapeutics for diabetes and obesity.

Ginkgo Bioworks Acquires AAV Capsid Technology and Forms Partnership for Next-Gen CAR-T Cell Therapies

April 14, 2023

Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.

AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery

April 14, 2023

The acquisition of Cell Systems will bolster AnaBios’ portfolio of human tissue and cells for use in drug discovery.

FDA Regulatory Authority Under Attack

April 10, 2023

Will court challenges to FDA’s oversight authority open the door for multiple lawsuits to block agency decisions on all sides?

J&J Proposes $8.9 Billion Payment in Talc Powder Litigation

April 07, 2023

If approved, Johnson & Johnson would pay $8.9 billion to resolve all current and future claims in its ongoing talc litigation.

Sartorius to Acquire Polyplus in $2.6 Billion Deal

April 05, 2023

Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.

A New Hope for Children Living with HIV

April 02, 2023

New child-friendly treatment options and initiatives are improving the outlook of children living with HIV in Europe.

Zauberkugel: Pfizer’s Seagen Acquisition

April 02, 2023

What can we take away from Pfifzer's acquisition of Seagen?

Who’s Got Game?

April 02, 2023

Direct-to-consumer drug advertising has developed as a cottage industry which has been used to increase prescriptions immensely.